We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Interactive Voice Response (IVR) for Methadone Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00237406
Recruitment Status : Completed
First Posted : October 12, 2005
Last Update Posted : March 25, 2010
Information provided by:
Butler Hospital

Brief Summary:
This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.

Condition or disease Intervention/treatment Phase
Opioid-Related Disorders Procedure: interactive voice response Phase 3

Detailed Description:

Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.

Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interactive Voice Response for Methadone Patients
Study Start Date : January 2006
Study Completion Date : October 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Individuals who recently enrolled in methadone maintenance for opioid addiction.

Inclusion Criteria:

  • Recent enrollment in a methadone maintenance program

Exclusion Criteria:

  • Enrollment in a methadone maintenance program within the prior 3 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00237406

United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Butler Hospital
Principal Investigator: Michael D Stein, MD Rhode Island Hospital

ClinicalTrials.gov Identifier: NCT00237406     History of Changes
Other Study ID Numbers: 4065-05
First Posted: October 12, 2005    Key Record Dates
Last Update Posted: March 25, 2010
Last Verified: March 2010

Keywords provided by Butler Hospital:
IVR, methadone
methadone maintenance

Additional relevant MeSH terms:
Opioid-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Antitussive Agents
Respiratory System Agents